Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03029182 · ClinicalTrials.gov registry record · NA

Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited Mobility

A NA study, sponsored by University of Alabama at Birmingham.

Completed
Registry status
NA
Development phase
15
Enrollment target

NCT03029182: Completed NA study, sponsored by University of Alabama at Birmingham.

NCT03029182 is a NA study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 15 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03029182, a NA study, has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
NA
Development phase
15 participants
Enrollment target

Study Summary

The study will evaluate the utility of hypoxic exercise training to improve cardiovascular and metabolic health among obese breast cancer survivors. While participants exercise, a lower fraction of inspired oxygen will be used to simulate a higher altitude. This approach removes the mechanical strain needed to sustain moderate-to-vigorous exercise intensity which is believed to support exercise tolerance. Participants are randomized to either the treatment (walking+simulated-altitude) or control (walking under normoxic conditions).

Primary Outcome

number of participants completing the 8 week session

Interventions

  • OTHER Walking+simulated-altitude
  • BEHAVIORAL Walking (control)

Trial Details

FieldValue
Enrollment Target 15 participants
Start Date 2016-10
Est. Completion 2018-04
Phase NA
University of Alabama at Birmingham

1,160 total trials

What the finished NCT03029182 record still lists

NCT03029182 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 15 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 2 interventions - of which Walking+simulated-altitude is the first listed.

NCT03029182 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03029182 about?

NCT03029182 is a clinical study titled "Simulated-altitude to Optimize Aerobic Exercise Among Breast Cancer Survivors With Limited Mobility". The study will evaluate the utility of hypoxic exercise training to improve cardiovascular and metabolic health among obese breast cancer survivors. While participants exercise, a lower fraction of inspired oxygen will be used to simulate a higher altitude. This approach removes the mechanical strai...

What is the current status of trial NCT03029182?

This trial is currently completed. It is a NA study. The enrollment target is 15 participants. The study started on 2016-10. Estimated completion is 2018-04.

What interventions are being tested in trial NCT03029182?

The interventions under investigation include: Walking+simulated-altitude (OTHER), Walking (control) (BEHAVIORAL).

Who is sponsoring clinical trial NCT03029182?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03029182's enrollment target sits among peer trials

15 1881st of 2000 higher than 92 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT01889381 · 15 participants · Phase 2

    Human Craniomaxillofacial Allotransplantation

  • NCT02530073 · 15 participants · NA

    Trial of Fetoscopic Endoluminal Tracheal Occlusion (FETO) for CDH

  • NCT02535936 · 15 participants · NA

    Cortical Plasticity in Spastic Diplegia After Selective Dorsal Rhizotomy

  • NCT02918474 · 15 participants · NA

    Decision Making Tool in Supporting Decision Making in Contralateral Prophylactic Mastectomy in Patients With Newly Diagnosed Breast Cancer

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT03029182, the US trial registry maintained by the National Library of Medicine. NCT03029182 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.